Join SightNation!

Become a citizen of our interactive community. Collaborate and network with your colleagues and trusted peers. Membership is free!

Connect with Colleagues

Link up with professionals all over the nation. Share your ideas, thoughts and opinions. Collaborate on difficult cases and offer your insights.

Communicate and Educate

Discuss new and important issues with your colleagues. Share your insights to help improve patient counseling. Post questions to your peers.

Learn and Advance

Take CE courses and rate courses for your peers. Find and apply for the newest jobs. Stay up-to-date on the latest eye care industry news.


Engage with SightNation citizens to help create real reform on issues affecting the industry. Start or join groups about the issues most important to you.

Create an account and receive access to the personalized box below.

Apply for Citizenship!
view counter

What’s Going On Across the Nation

New Blog Postings

SightNation News

Featured News

MediNiche Introduces Updated OcuDerma Eye Gel - 11.25.2016

OcuDerma eye gel, formulated as a smooth, non-oily and non-sticky gel containing advanced technology peptides to help reduce under-eye bag volume by decreasing capillary permeability, improving lympha More »

Featured News

Report Explores Gap Between Managed Care & ECPs - 11.23.2016

The Eye Care Trend Report, Volume II, supported by Allergan, is a 40-page report that examines and compares the perspectives of managed care organizations, ophthalmologists and optometrists on current More »

Featured News

Ocular Therapeutix Announces Positive Topline Results from Phase III Trial - 11.21.2016

Ocular Therapeutix announced positive topline results from its Phase III clinical trial of Dextenza (dexamethasone insert) 0.4 mg for the treatment of post-surgical ocular inflammation and pain. More »

Featured News

ECL Adds Integrity EMR to Practice Solutions Suite - 11.17.2016

Eye Care Leaders announced the addition of Integrity electronic medical record to its suite of electronic health records and practice solutions for eye care. More »

AGTC Files IND for Treatment of Achromatopsia Due to CNGA3 Mutations - 11.16.2016

Applied Genetic Technologies Corp. filed an Investigational New Drug application with the U.S. More »

Copyright © 2010-2015 Jobson Medical Information LLC. All Rights Reserved.